Inspire Medical Systems (INSP) Stock Forecast & Price Target

$178.36 -0.36 (-0.20%)

Closing price 02/20/2025 03:58 PM Eastern

Extended Trading

$178.41 +0.05 (+0.03%)

As of 02/20/2025 07:30 PM Eastern

Inspire Medical Systems - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 11 Analyst Ratings

Sell
0

Hold
3

Buy
8

Based on 11 Wall Street analysts who have issued ratings for Inspire Medical Systems in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 11 analysts, 3 have given a hold rating, and 8 have given a buy rating for INSP.

Consensus Price Target

$228.82
28.29% Upside

According to the 11 analysts' twelve-month price targets for Inspire Medical Systems, the average price target is $228.82. The highest price target for INSP is $260.00, while the lowest price target for INSP is $190.00. The average price target represents a forecasted upside of 28.29% from the current price of $178.36.

Get the Latest News and Ratings for INSP and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Inspire Medical Systems and its competitors.

INSP Analyst Ratings Over Time

Type	Current Forecast 2/22/24 to 2/21/25	1 Month Ago 1/23/24 to 1/22/25	3 Months Ago 11/24/23 to 11/23/24	1 Year Ago 2/22/23 to 2/22/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	8 Buy rating(s)	9 Buy rating(s)	8 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$228.82	$231.64	$233.58	$272.92
Forecasted Upside	28.29% Upside	22.64% Upside	23.77% Upside	46.88% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

INSP Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

INSP Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Inspire Medical Systems Stock vs. The Competition

Type	Inspire Medical Systems	Medical Companies	S&P 500
Consensus Rating Score	2.73	2.82	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	28.29% Upside	29,063.69% Upside	12.83% Upside
News Sentiment Rating	Positive News See Recent INSP News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
2/11/2025	Truist Financial 2 of 5 stars	Richard Newitter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$250.00 ➝ $235.00	+31.86%
2/11/2025	Royal Bank of Canada 4 of 5 stars	Shagun Singh Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$260.00 ➝ $260.00	+44.81%
2/11/2025	Robert W. Baird 2 of 5 stars	Mike Polark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$252.00 ➝ $248.00	+37.05%
2/11/2025	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kallum Titchmarsh Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$230.00 ➝ $220.00	+21.57%
2/11/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Larry Biegelsen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$198.00 ➝ $195.00	+7.76%
2/10/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Adam Maeder Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$260.00 ➝ $233.00	+28.02%
1/24/2025	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brett Fishbin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$236.00 ➝ $234.00	+26.13%
1/21/2025	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jonathan Block Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Hold ➝ Hold	$200.00 ➝ $190.00	+3.22%
11/20/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$220.00 ➝ $255.00	+44.85%
9/10/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$167.00 ➝ $197.00	-7.78%
Get the Latest News and Ratings for INSP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter.
3/27/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$250.00	+17.18%
1/19/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$245.00	+26.70%
10/17/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$340.00 ➝ $181.00	+14.23%
10/16/2023	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Kratky Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform
9/6/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$405.00 ➝ $322.00	+37.43%
8/2/2023	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$305.00 ➝ $350.00	+22.64%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 07:24 AM ET.

INSP Forecast - Frequently Asked Questions

: According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Inspire Medical Systems is $228.82, with a high forecast of $260.00 and a low forecast of $190.00.
: 11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last twelve months. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" INSP shares.
: According to analysts, Inspire Medical Systems's stock has a predicted upside of 28.29% based on their 12-month stock forecasts.
: Inspire Medical Systems has been rated by research analysts at KeyCorp, Morgan Stanley, Piper Sandler, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, Truist Financial, and Wells Fargo & Company in the past 90 days.
: Analysts like Inspire Medical Systems less than other "medical" companies. The consensus rating score for Inspire Medical Systems is 2.73 while the average consensus rating score for "medical" companies is 2.82. Learn more on how INSP compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:INSP) was last updated on 2/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Inspire Medical Systems (INSP) Stock Forecast & Price Target